Treatment of Early-Stage Hodgkin Lymphoma: Are We Just Shifting Morbidities?-Reference-Cited by-同舟云学术

Treatment of Early-Stage Hodgkin Lymphoma: Are We Just Shifting Morbidities?

Published:2017-08-20 Issue:24 Volume:35 Page:2849-2850
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Vargo John A.¹,Ling Diane C.¹,Beriwal Sushil¹

Affiliation:

1. John A. Vargo, University of Pittsburgh Cancer Institute, Pittsburgh, PA; and West Virginia University, Morgantown, WV; and Diane C. Ling and Sushil Beriwal, University of Pittsburgh Cancer Institute, Pittsburgh, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.73.3568

Reference6 articles.

1. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

2. Treatment Selection and Outcomes in Early-Stage Classical Hodgkin Lymphoma: Analysis of the National Cancer Data Base

3. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

4. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

5. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al;Journal of Clinical Oncology;2017-08-20

2. Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al;Journal of Clinical Oncology;2017-08-20